# NKX6-2

## Overview
NKX6-2 is a gene that encodes the NK6 homeobox 2 protein, a transcription factor involved in the regulation of gene expression during the development and maturation of oligodendrocytes in the central nervous system (CNS). The NK6 homeobox 2 protein is characterized by a homeobox domain, which facilitates its role as a sequence-specific DNA-binding transcription factor, crucial for myelination and neural development (Hosseini2020Expanding; Chelban2017Mutations). This protein acts as a repressor, influencing axon-glial interactions and myelin formation, and is essential for maintaining normal neurological function (Chelban2017Mutations). Mutations in the NKX6-2 gene have been linked to hereditary spastic ataxia type 8 and other neurological disorders, highlighting its clinical significance in CNS development and function (Hosseini2020Expanding; Chelban2017Mutations).

## Structure
The NKX6-2 protein, encoded by the NKX6-2 gene, is a transcription factor consisting of 277 amino acids (Hosseini2020Expanding). It contains a homeobox domain, a highly conserved DNA-binding motif, which spans from amino acids 148 to 207 (Hosseini2020Expanding). This domain is crucial for binding to specific DNA sequences, such as the 5'-(A/T)TTAATGA-3′ consensus sequence found in the promoter regions of genes like myelin basic protein (MBP) (Hosseini2020Expanding). The homeobox domain typically forms a helix-loop-helix-turn-helix structure, which is essential for its DNA-binding function (Chelban2017Mutations).

Mutations affecting the homeobox domain, such as the p.Leu163Val variant, can disrupt the protein's structure and function, leading to deleterious effects (Chelban2017Mutations). The NKX6-2 protein functions as a sequence-specific DNA-binding transcription factor and acts as a repressor in regulating axon-glial interactions at myelin paranodes in oligodendrocytes (Hosseini2020Expanding). The protein's role in myelination and neural development is underscored by its involvement in pathways associated with oligodendrocyte maturation and myelin formation (Chelban2017Mutations).

## Function
The NKX6-2 gene encodes a transcriptional repressor that plays a critical role in the central nervous system (CNS), particularly in the maturation of oligodendrocytes, which are essential for myelination. Myelination is crucial for proper nervous system function, as it ensures adequate and measured myelination necessary for critical functions and brain plasticity (Chelban2017Mutations). NKX6-2 functions as a transcription factor, regulating the expression of genes involved in oligodendrocyte development and myelination. It operates in the nucleus, where it binds DNA in a sequence-specific manner through its highly conserved homeobox domain, influencing gene regulation (Chelban2017Mutations).

In healthy human cells, NKX6-2 is expressed in the developing and adult brain, with the highest expression in the spinal cord and substantia nigra. It is also highly expressed in intralobular white matter, where it regulates a network of genes involved in CNS development and cytoskeletal protein binding (Chelban2017Mutations). The gene's activity is crucial for maintaining normal myelin generation and neurological function, as evidenced by the severe motor and behavioral deficits observed in cases of NKX6-2 deficiency (Chelban2017Mutations).

## Clinical Significance
Mutations in the NKX6-2 gene are associated with hereditary spastic ataxia type 8, a condition characterized by hypomyelinating leukodystrophy. This disorder presents with a range of symptoms, including global developmental delay, motor regression, hypotonia, spasticity, scoliosis, and nystagmus. A novel missense variant, c.501C > G; p.(Phe167Leu), was identified in two siblings from Iran, marking the first report of this variant in the country. This variant is predicted to be damaging and is associated with peripheral axonal neuropathy, a feature not previously reported in NKX6-2 related disorders, suggesting a phenotypic expansion (Hosseini2020Expanding).

Other mutations in NKX6-2, such as a homozygous premature stop mutation (c.121A>T; p.Lys41*) and a missense variant (c.487C>G; p.Leu163Val), have been linked to progressive spastic ataxia and hypomyelination. These mutations result in a loss of function of the NKX6-2 protein, which is crucial for the development of the central nervous system and myelin maintenance (Chelban2017Mutations). The gene's role in oligodendrocyte maturation and myelin formation underscores its importance in maintaining normal neurological function (Chelban2017Mutations).

## Interactions
NKX6-2, a transcription factor, is involved in the regulation of gene expression during the development and maturation of oligodendrocytes. It interacts with other proteins and nucleic acids to influence cellular processes such as differentiation and myelination. NKX6-2 is known to co-localize with NKX2.2 in differentiated myelinating oligodendrocytes, suggesting a potential interaction between these two homeodomain proteins in regulating myelin sheath formation and maintenance (Cai2009Co‐localization). The expression of NKX6-2 is dependent on NKX2.2, as the absence of NKX2.2 leads to inhibited oligodendrocyte differentiation and a lack of NKX6-2 expression, indicating that these proteins may be part of the same regulatory pathway (Cai2009Co‐localization).

NKX6-2 also plays a role in the regulation of cytoskeletal dynamics, particularly through its influence on stathmin 1, a microtubule-destabilizing protein. In Nkx6-2 null mice, reduced levels of stathmin 1 suggest a disruption in paranode function, which is crucial for maintaining normal paranodal structure and function (Southwood2004CNS). These interactions highlight the importance of NKX6-2 in the structural organization of myelin paranodes and its involvement in axon-glial interactions (Southwood2004CNS).


## References


[1. (Hosseini2020Expanding) Ali Hosseini Bereshneh, Sareh Hosseipour, Maryam Sadat Rasoulinezhad, Neda Pak, Masoud Garshasbi, and Ali Reza Tavasoli. Expanding the clinical and neuroimaging features of nkx6-2-related hereditary spastic ataxia type 8. European Journal of Medical Genetics, 63(5):103868, May 2020. URL: http://dx.doi.org/10.1016/j.ejmg.2020.103868, doi:10.1016/j.ejmg.2020.103868. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejmg.2020.103868)

[2. (Cai2009Co‐localization) Jun Cai, Qiang Zhu, Kang Zheng, Hong Li, Yingchuan Qi, Qilin Cao, and Mengsheng Qiu. Co‐localization of nkx6.2 and nkx2.2 homeodomain proteins in differentiated myelinating oligodendrocytes. Glia, 58(4):458–468, September 2009. URL: http://dx.doi.org/10.1002/glia.20937, doi:10.1002/glia.20937. This article has 84 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/glia.20937)

[3. (Southwood2004CNS) Cherie Southwood, Chris He, James Garbern, John Kamholz, Edgardo Arroyo, and Alexander Gow. Cns myelin paranodes require nkx6-2 homeoprotein transcriptional activity for normal structure. The Journal of Neuroscience, 24(50):11215–11225, December 2004. URL: http://dx.doi.org/10.1523/JNEUROSCI.3479-04.2004, doi:10.1523/jneurosci.3479-04.2004. This article has 103 citations.](https://doi.org/10.1523/JNEUROSCI.3479-04.2004)

[4. (Chelban2017Mutations) Viorica Chelban, Nisha Patel, Jana Vandrovcova, M. Natalia Zanetti, David S. Lynch, Mina Ryten, Juan A. Botía, Oscar Bello, Eloise Tribollet, Stephanie Efthymiou, Indran Davagnanam, Fahad A. Bashiri, Nicholas W. Wood, James E. Rothman, Fowzan S. Alkuraya, and Henry Houlden. Mutations in nkx6-2 cause progressive spastic ataxia and hypomyelination. The American Journal of Human Genetics, 100(6):969–977, June 2017. URL: http://dx.doi.org/10.1016/j.ajhg.2017.05.009, doi:10.1016/j.ajhg.2017.05.009. This article has 41 citations.](https://doi.org/10.1016/j.ajhg.2017.05.009)